upshyatmak study of lekhaniya mahakashya on sthaulya (hyperlipidemia)
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- 1.Reduce symptoms of obesity and relief of symtoms
研究概览
简要总结
Obesity is a prevalent nutritional disorder in which energy intake exceeds the energy output over a sufficiently long period of time and energy stores of the body remain too large, although the genetic component to obesity remains a possibility, it is unlikely to be great or to prevent weight loss being possible in most patient by reducing energy intake. environmental influences are believed to be more important in explaining the familial association in obesity.An inactive lifestyle is thought to play a role in the development of obesity.
**Drugs-**Lekhaniya mahakashaya
Dose- 48 gm BD with luke warm water
Study type-Interventional
**Study time-**18 Months
Interventional time-40 Days
Sample size-20 Patient in each group
Group1- Lekhaniya mahakashaya kwath
Group2- pathya ahar vihar and yoga asan and exerscise
Assessment criteria-
Subjective criteria- chal sphik, utsaha hani,ksudra swas,atinidra,swedadhikya,anga daurgandhya,anga gauravata,ati pipasa,ati ksuda
Objective criteria- chest, abdomen, hip, mid thigh, mid arm, BMI range (kg/m2)
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 20.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •The well diagnostic pt.of sthaulya (Hyperlipidemia)will be selected s.cholesterol->200mg/dl s.
- •triglyceride- > 150mg/dl s.LDL- >110 S.VLDL-> 40mg/dl.
排除标准
- •suffering with any systemic disease like cardiac and renal disease hypertention.
- •pt suffering for endocrine disorder like diabetes thyroid dysfunction etc.
- •pregnant females and lactating females.
结局指标
主要结局
1.Reduce symptoms of obesity and relief of symtoms
时间窗: 18 month
like atinidra,chala sphik,utsaha hani,kshudra shawas anga daurgandhya etc
时间窗: 18 month
次要结局
- 1.aetiopathogenesis of sthaulya will be assessed by adopting suitable subjective parameters.(2.Decrease elevated level of s.cholesterol s.triglyceride s. LDL S.VLDL Etc.)